lab SARS-CoV-2 Na'urar Gwajin Antibody AMRPA73 na siyarwa

Cikakken Bayani

Misalai: Magani/Plasma/Jini Duka/
Lokacin Karatu: Minti 10
Ajiye @ 2°C -30°C, kariya daga haske
Girman: Gwaji 20/Kit, Gwaji 40/Kit

Marufi & Bayarwa

Ƙayyadaddun bayanai

Lab SARS-CoV-2 Na'urar Gwajin Gwajin Jiyya na AMRPA73 fasali

Misalai: Magani/Plasma/Jini Duka/

Lokacin Karatu: Minti 10

Ajiye @ 2°C -30°C, kariya daga haske
Girman: Gwaji 20/Kit, Gwaji 40/Kit

lab SARS-CoV-2 Na'urar maganin rigakafi AMRPA73 Gabatarwa

LgM da lgG rigakafi sune farkon ƙwayoyin rigakafin da ke bayyana a cikin tsarin rigakafi yayin kamuwa da cutar ɗan adam tare da cututtukan SARS-CoV2.Kwayar cutar coronavirus takamaiman lgM antibody zai bayyana a farkon mako guda bayan kamuwa da cuta, sannan lgG antibody zai bayyana.Akwai 'yan bambance-bambance a matakai daban-daban na cutar da nau'i daban-daban na daidaikun mutane.

Zai kai kololuwa a cikin mawuyacin lokaci ko farkon murmurewa.Yana iya tabbatar da cewa marasa lafiya a kowane mataki ba a rasa su ba, kuma zai iya ƙayyade hanya da mataki na majiyyaci, da kuma jagorantar likitocin don kula da marasa lafiya da wuri da niyya, da kuma muhimmiyar alamar kula da marasa lafiya na asibiti.